- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Relapsed or Refractory Multiple Myeloma in New Zealand
Total 1520 results
-
Indapta Therapeutics, INC.RecruitingMultiple Myeloma | Refractory Multiple Myeloma | Refractory Non-Hodgkin Lymphoma | NHL | Blood Cancer | Relapsed Multiple Myeloma | Relapsed Non-Hodgkin LymphomaUnited States
-
Ichnos Sciences SARecruitingRelapsed/Refractory Multiple MyelomaUnited States, Australia
-
Epizyme, Inc.RecruitingDiffuse Large B-Cell Lymphoma | Diffuse Large B Cell Lymphoma Refractory | Multiple Myeloma in Relapse | Multiple Myeloma, RefractoryUnited States
-
Gracell Biopharmaceuticals, Inc.RecruitingRelapsed/ Refractory Multiple MyelomaUnited States
-
Celyad Oncology SAActive, not recruitingRelapse/Refractory Multiple MyelomaBelgium, United States
-
NexImmune Inc.SuspendedRelapsed Refractory Multiple MyelomaUnited States
-
AmgenCompletedRelapsed or Refractory Multiple MyelomaFrance, Czechia, Sweden, United States, Greece, Spain, Finland, Romania, Germany, Japan, Netherlands, Turkey, Austria, Bulgaria, Lithuania, Russian Federation, Slovakia
-
AbbVieRecruitingRelapsed/Refractory Multiple MyelomaUnited States, Australia, Israel, United Kingdom
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed and/or Refractory Multiple MyelomaUnited States, France, Norway, Spain, Israel, United Kingdom, Italy, Australia, Germany, Greece, Canada, Czechia, Turkey, Russian Federation, Denmark, Sweden, Belgium, Netherlands
-
Regeneron PharmaceuticalsActive, not recruitingRelapsed and Refractory Multiple Myeloma (RRMM)United States
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.RecruitingRelapsed/Refractory Multiple MyelomaUnited States, France
-
Novartis PharmaceuticalsCompletedRelapsed or Refractory Multiple MyelomaUnited States, Turkey, Canada, Netherlands, Australia, Germany, France
-
Cellectis S.A.TerminatedRelapsed/Refractory Multiple MyelomaUnited States
-
Caribou Biosciences, Inc.RecruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Kite, A Gilead CompanyTerminatedRelapsed/Refractory Multiple MyelomaUnited States
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Belgium, France, Norway
-
Xencor, Inc.TerminatedRelapsed/ Refractory Multiple MyelomaUnited States, Australia
-
Allogene TherapeuticsActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
AstraZenecaTerminatedRelapsed or Refractory Acute Myeloid Leukemia (AML)United States
-
AmgenTerminatedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Japan, Germany, Netherlands, Canada
-
TeneoOne Inc.RecruitingRelapsed/Refractory Multiple MyelomaAustralia, Germany, Japan, Spain, United States, Italy, Poland
-
National Cancer Institute (NCI)CompletedRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Cougar Biotechnology, Inc.TerminatedRefractory Multiple MyelomaUnited States
-
SanofiRecruitingRelapsed/Refractory Multiple MyelomaCzechia, Japan, Australia, Brazil, Greece, Portugal
-
Roswell Park Cancer InstituteRecruitingPlasma Cell Myeloma | Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Smoldering Plasma Cell MyelomaUnited States
-
Merck Sharp & Dohme LLCTerminatedRelapsed or Refractory Acute Myeloid Leukemia | Relapsed or Refractory Chronic Myelomonocytic LeukemiaUnited States, Israel, Spain
-
National Cancer Institute (NCI)RecruitingPlasmacytoma | Refractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Janssen Research & Development, LLCRecruitingRelapsed/ Refractory Multiple MyelomaUnited States, Germany, Spain, France
-
OncotherapeuticsWithdrawnStage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Plasma Cell NeoplasmUnited States
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple Myeloma | Previously Treated Amyloid Light-chain (AL) AmyloidosisBelgium, United States, United Kingdom, Spain, France, Netherlands
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Regeneron PharmaceuticalsRecruitingRelapsed Refractory Multiple Myeloma (RRMM)Canada, United States, Korea, Republic of, Israel, Taiwan, Spain, Australia, Brazil, France, United Kingdom, Poland, Singapore, Italy
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingRelapsed or Refractory Solid TumorsUnited States, Argentina, Australia, Belgium, Croatia, Czechia, France, Guatemala, Hungary, Israel, Italy, Korea, Republic of, New Zealand, Peru, Russian Federation, Serbia, South Africa, Spain, Sweden, Turkey
-
Hackensack Meridian HealthMerck Sharp & Dohme LLCWithdrawnMultiple Myeloma, RefractoryUnited States
-
OncoMed Pharmaceuticals, Inc.CompletedRelapsed or Refractory Lymphoid MalignanciesUnited States
-
University of ChicagoNational Cancer Institute (NCI)RecruitingRefractory Multiple MyelomaUnited States
-
Yale UniversityVanderbilt UniversityCompletedRelapsed/Refractory Acute Myeloid LeukemiaUnited States
-
Actinium PharmaceuticalsTerminatedRefractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Cleave Biosciences, Inc.TerminatedLymphoid Hematological Malignancies | Relapsed and Refractory Multiple MyelomaCanada, United States
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Brazil, Canada, France, Germany, Hungary, Ireland, Italy, Japan, Korea, Republic of, Russian Federation, Spain, Taiwan, Ukraine, United Kingdom
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)TerminatedRefractory Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell Myeloma | DS (Durie/Salmon) Stage I Plasma Cell MyelomaUnited States
-
Roswell Park Cancer InstituteBristol-Myers SquibbActive, not recruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Mundipharma-EDO GmbHTerminatedMultiple Myeloma in Relapse | Multiple Myeloma With Failed Remission | Multiple Myeloma ProgressionSwitzerland, United States, Norway
-
Roswell Park Cancer InstituteCelgeneActive, not recruitingPlasma Cell Myeloma | Partial Response of Multiple Myeloma or Plasma Cell LeukemiaUnited States
-
Cornerstone PharmaceuticalsTerminatedRelapsed/Refractory Acute Myeloid LeukemiaUnited States, Spain, Korea, Republic of, France, Australia, Belgium, Austria, Germany, Poland
-
Celyad Oncology SAUnknownAcute Myeloid Leukemia/Myelodysplastic Syndrome | Multiple Myeloma (MM)United States, Belgium
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Harpoon TherapeuticsActive, not recruitingMultiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma With Failed Remission | Multiple Myeloma of BoneUnited States, Spain, France
-
Cellectis S.A.RecruitingRelapsed/Refractory Acute Myeloid LeukemiaUnited States